CogMe

Company Overview

Snapshot

Founded in December 2020 by Liat Feinberg and Ilan Ben Oren, CogMe operates with 1–10 employees. The company has raised $1.4 million across one funding round from 4 investors. In January 2021, MindUP invested in CogMe, highlighting its focus on detecting and preventing delirium.

Business overview

CogMe is a Health Tech & Life Sciences company focused on improving health outcomes for older adults. The company leverages AI to provide a holistic solution that analyzes cognitive, physiological, and activity indicators to predict, detect, and intervene in the decline of patients in both inpatient and outpatient settings. Its expert system applies clinical guidelines and machine learning to offer actionable data for personalized care plans, initially concentrating on delirium. CogMe serves the healthcare industry, targeting healthcare providers, hospitals, and patients, particularly seniors, with solutions in digital healthcare, health management, and medical decision support.

Strategic signal

In January 2021, MindUP invested in CogMe, signaling validation for the company's AI-driven approach to addressing cognitive and physiological decline. This investment underscores the market's recognition of innovative solutions for an unmet need in senior care, particularly in the prevention and detection of delirium, and positions CogMe for further development in personalized care plans.

Company Intelligence Q&A

When was CogMe founded?

CogMe was founded in December 2020.

Who are the founders of CogMe?

CogMe was co-founded by Liat Feinberg and Ilan Ben Oren.

What is CogMe's primary focus?

CogMe focuses on improving health outcomes by reducing cognitive and physiological deterioration in older adults at risk, using AI to predict, detect, and intervene to prevent decline.

How much capital has CogMe raised to date?

CogMe has raised a total of $1.4 million across one funding round.